However, using the same functionalization strategy, our nanorods could be conjugated with different antibodies for different EV surface markers such as EpCAM, which is overexpressed in many types of cancers [92–97] or claudin 1,7, and Cadherin-17, which are specific for colorectal cancer [92, 96–98]. Here, CLDN1 is linked to colorectal cancer.